Aberrations of genomic DNA methylation have been confirmed to be involved in the evolution of human cancer and have thus gained the potential to be depicted as biomarkers for cancer diagnostics and prognostic predictions, which implicates an urgent need for detection of total genomic DNA methylation. In this work, we suggested an assay for the quantification of global DNA methylation, utilizing methylation specific antibody (5mC) modified magnetic beads (MBs) for immunorecognition and affinity enrichment. Subsequently, the captured DNA on the surface of MBs interacted with the glucose oxidase-conjugated DNA antibody whose catalytic reaction product was engaged in electrochemical detection of the overall level of DNA methylation on a PB-doped screen-printed electrode. With 15 pg of input DNA, which, to our best knowledge, is the lowest required amount of DNA without sodium bisulfite treatment or amplification, this test strategy was able to perceive as low as 5% methylation level within 70 min including the preparation of anti-5mC-MBs. We believe this detection technique offers a promising option to detect global DNA methylation in both academic and clinical scenarios.
Keyphrases
- dna methylation
- genome wide
- copy number
- label free
- gene expression
- circulating tumor
- molecularly imprinted
- cell free
- single molecule
- nucleic acid
- loop mediated isothermal amplification
- papillary thyroid
- endothelial cells
- high throughput
- healthcare
- gold nanoparticles
- real time pcr
- sensitive detection
- climate change
- squamous cell carcinoma
- metabolic syndrome
- insulin resistance
- high resolution
- risk assessment
- photodynamic therapy
- single cell
- blood glucose
- human health
- mass spectrometry
- medical students